01 · Mechanism
A different route
Bremelanotide activates melanocortin receptors (mainly MC4R) in the brain, a pathway involved in sexual desire and arousal. Sildenafil and tadalafil work on blood vessels instead.
PT-141 (bremelanotide) is a peptide that activates melanocortin receptors in the brain, a pathway involved in sexual desire and arousal. It does not work on blood flow the way ED pills do. Bremelanotide is FDA-approved, as the Vyleesi® autoinjector, only for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD). The compounded PT-141 prescribed here is not FDA-approved and is not Vyleesi; any other use, including use in men, is off-label and a clinician decision. If prescribed, a licensed U.S. pharmacy prepares it and your clinician sets the dose and how often you use it.
Clinician review, your medication if prescribed, care-team messaging and free, discreet shipping.
Compounded PT-141 is not FDA-approved and is not Vyleesi. Nausea is very common, especially with the first doses, and vomiting can happen. Flushing, headache and injection-site reactions are also common. It can temporarily raise blood pressure and lower heart rate after a dose, so it is not for people with uncontrolled high blood pressure or known cardiovascular disease. Repeated use can darken areas of skin, such as the face, gums or breasts, and this may not fully go away. It can slow how your body absorbs some oral medicines, such as naltrexone. Not for use during pregnancy. A licensed clinician reviews your health history and medications and decides whether it's appropriate. See the medical disclaimer.
Your card is authorized at checkout and only charged if a clinician approves you. If approved, it ships free in plain packaging. Monthly is $219 a month until you cancel. The 3-month prepaid plan is one $499 payment and doesn't renew automatically.
Renews monthly until you cancel
Clinician review included · Free shipping if prescribedMost ED pills work on blood flow. PT-141 takes a different route: it acts on receptors in the brain linked to desire. Talk it through with a licensed clinician who gives you the straight story, privately and online.
Vyleesi® is a registered trademark of its owner. FutureSelf RX is not affiliated with it, and compounded PT-141 is not Vyleesi.
Vyleesi is FDA-approved only for premenopausal women with acquired, generalized HSDD. Compounded PT-141 is not FDA-approved and is not Vyleesi; use in men is off-label.
No waiting rooms, no awkward conversations. Here's exactly how it works.
A short, private online visit: your goals, health history, blood pressure and current medications. Your card is authorized, not charged.
A U.S.-licensed clinician reviews whether PT-141 fits you, follows up if needed, and only prescribes if it does.†
If prescribed, it ships free in plain packaging. Message your care team about side effects or dosing anytime, and cancel whenever you want.
†Review times vary. Payment does not guarantee a prescription.
Bremelanotide activates melanocortin receptors (mainly MC4R) in the brain, a pathway involved in sexual desire and arousal. Sildenafil and tadalafil work on blood vessels instead.
Two 24-week trials (RECONNECT) studied bremelanotide in premenopausal women with HSDD. Those trials led to the FDA approving Vyleesi in 2019 for that group. Results vary from person to person.
Compounded PT-141 isn't FDA-approved and isn't Vyleesi. Research in men is limited, so any use in men is off-label. That's exactly why a licensed clinician reviews it with you first.
A short online visit covering your goals, history, and anything else your clinician should know.
A licensed clinician reviews your answers, follows up if needed, and prescribes what fits.
Treatment ships free in plain packaging, with refills on a schedule that suits you.
Message your care team anytime. Adjust dose, switch treatments, or pause — no appointment needed.
Swipe to explore the four steps